SCHEMBL67000

SCHEMBL67000

c1cc2[nH]ccc2cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL709416 1.00 PDE3B (0.50) —
SCHEMBL30205720 1.00 — —
Iodide SCHEMBL18952073 0.98 PDE3B (0.48) —
SCHEMBL28112440 0.98 — —
Ammonia Solution, Strong SCHEMBL27929463 0.98 PDE3B (0.48) —
Hydrochloric Acid SCHEMBL884599 0.98 PDE3B (0.48) —
Bromide SCHEMBL2722104 0.98 PDE3B (0.48) —
SCHEMBL5568512 0.98 PDE3B (0.48) —
SCHEMBL5568504 0.98 PDE3B (0.48) —
SCHEMBL17372872 0.92 MAPT (0.45) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 5423 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4482583-B1 ZWITTERIONIC ANTIBACTERIAL COMPOUNDS HOFFMANN LA ROCHE (CH) 2026-04-01 — — EP claimed
US-12528822-B2 Cycloalkane-1,3-diamine derivative DAIICHI SANKYO COMPANY, LIMITED (JP) 2026-01-20 — — US claimed
EP-4678634-A1 ANDROGEN RECEPTOR MODULATORS AND USES THEREOF Haihe Biopharma Co., Ltd. (CN) 2026-01-14 — — EP claimed
US-20250215030-A1 STAT MODULATORS AND USES THEREOF RECLUDIX PHARMA, INC. 2025-07-03 — — US claimed
US-20250179066-A1 ZWITTERIONIC ANTIBACTERIAL COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2025-06-05 — — US claimed
EP-4200298-B1 1H-PYRROLO[3,2-C]PYRIDINE AND 1H-PYRROLO[2,3-C]PYRIDINE DERIVATIVES AS TLR9 INHIBITORS FOR THE TREATMENT OF FIBROSIS BRISTOL MYERS SQUIBB CO (US) 2025-05-21 — — EP claimed
WO-2025082069-A1 COMPOUND BINDING TO CRBN PROTEIN AND DEGRADATION AGENT OF PROTEIN 中国海洋大学 2025-04-24 — — WO claimed
CN-119841843-A Compound combined with CRBN protein and degradation agent of CRBN protein 中国海洋大学 2025-04-18 — — CN claimed
WO-2025076059-A1 ROCAGLATE DERIVATIVES AND USES THEREOF TRUSTEES OF BOSTON UNIVERSITY (US) 2025-04-10 — — WO claimed
CN-119674006-A Phosphorus-based negative electrode material with coating structure and preparation method and application thereof 南京宁嘉新材料科技有限公司 2025-03-21 — — CN claimed
WO-2001005758-A2 INDOLES AND INDAZOLES FOR THE TREATMENT OF MIGRAINE NPS ALLELIX CORP. (CA) 2001-01-25 — — WO claimed
WO-2000075139-A2 BENZOTHIAZINONE AND BENZOXAZINONE COMPOUNDS BASF AKTIENGESELLSCHAFT (DE) 2000-12-14 — — WO claimed
CN-1043642-C Herbicidal pyrrolopyridine compounds ZENECA LTD (GB) 1999-06-16 — — CN claimed
CN-1137795-A Herbicidal pyrrolopyridine compounds ZENECA LTD (GB) 1996-12-11 — — CN claimed
EP-0187631-B1 PROCESS FOR THE PREPARATION OF PYRROLOPYRIDINE DERIVATIVES, AND DERIVATIVES SO OBTAINED SANOFI (FR) 1990-09-05 — — EP claimed
US-4831144-A 1H-pyrrolo [3,2-c]pyrrolidines protected in 1-position useful as intermediates SANOFI (FR) 1989-05-16 — — US claimed
EP-0165225-B1 PROCESS FOR THE PREPARATION OF 5-AZAINDOLE AND INTERMEDIATES SANOFI S.A. (FR) 1988-03-23 — — EP claimed
US-4625033-A 3-METHYL-4-NITROPYRIDINE-1-OXIDE CONDENSED TO ENAMINE, CATALYTIC REDUCTION CYCLIZATION SANOFI (FR) 1986-11-25 — — US claimed
EP-0187631-A1 Process for the preparation of pyrrolopyridine derivatives, and derivatives so obtained SANOFI (FR) 1986-07-16 — — EP claimed
EP-0165225-A1 Process for the preparation of 5-azaindole and intermediates SANOFI S.A. (FR) 1985-12-18 — — EP claimed
Send feedback